Other Publication Details
Mandatory Fields
Reviews
Cronin, CG,Swords, R,Truong, MT,Viswanathan, C,Rohren, E,Giles, FJ,O'Dwyer, M,Bruzzi, JF
2010
January
Clinical Utility of PET/CT in Lymphoma
Published
1
Optional Fields
lymphoma PET/CT POSITRON-EMISSION-TOMOGRAPHY NON-HODGKINS-LYMPHOMA CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELL LYMPHOMA F-18 FDG-PET MALIGNANT-LYMPHOMA PROGNOSTIC VALUE POSTTREATMENT EVALUATION AGGRESSIVE LYMPHOMA RESPONSE ASSESSMENT
OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options.CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.
91
103
DOI 10.2214/AJR.09.2637
Grant Details
Publication Themes